Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May;9(5):1163-71.
doi: 10.4161/hv.23802. Epub 2013 Feb 1.

Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines

Daniela Amicizia  1 , Alexander Domnich, Donatella Panatto, Piero Luigi Lai, Maria Luisa Cristina, Ulderico Avio, Roberto Gasparini
Affiliations
Review

Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines

Daniela Amicizia et al. Hum Vaccin Immunother. 2013 May.

Abstract

Tick-borne Encephalitis (TBE), which is caused by a Flavivirus, is the most common tick-transmitted disease in Central and Eastern Europe and Russia. Today, TBE is endemic in 27 European countries, and has become an international public health problem. The epidemiology of TBE is changing owing to various factors, such as improvements in diagnosis and case reporting, increased recreational activities in areas populated by ticks, and changes in climatic conditions affecting tick habitats. Vaccination remains the most effective protective measure against TBE for people living in risk zones, occupationally exposed subjects and travelers to endemic areas. The vaccines currently in use are FSME-Immun(®), Encepur(®), EnceVir(®) and TBE vaccine Moscow(®). The numerous studies performed on the efficacy and safety of these vaccines have shown a high level of immunogenicity and an excellent safety profile. Several studies have also shown a high level of cross-protection among strains belonging to different subtypes. In the present paper we attempted to describe the continuously changing epidemiology of TBE in European States and to overview clinical development of available vaccines paying particular attention on cross-protection elicited by the vaccines.

Keywords: TBE vaccines; epidemiology; prevention; tick-borne encephalitis; vaccine cross-protection.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Schneider H. Über epidemische akute. Klin Wochenschr. 1931;44:350–2.
    1. Silber LA, Soloviev VD. Far Eastern tick-borne spring-summer (spring) encephalitis. Am Rev Sov Med. 1946;(Suppl):1–80. - PubMed
    1. Gallia F, Rampas J, Hollender L. Laboratory infection caused by tick-borne encephalitis virus. Cas Lek Cesk. 1949;88:224–9.
    1. Süss J. Tick–borne encephalitis in Europe and beyond - the epidemiological situation as of 2007. Euro Surveill 2008; 13(26):pii=18916. - PubMed
    1. Süss J. Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview. Ticks Tick Borne Dis. 2011;2:2–15. doi: 10.1016/j.ttbdis.2010.10.007. - DOI - PubMed

MeSH terms